Read More Pharma Industry News How CLD-401 and RedTail may redefine tumor-localized immune activation in solid tumors Can RedTail and CLD-401 change solid tumor immunotherapy? Read why Calidi Biotherapeutics, Inc.’s next milestones could reshape the CLDI story. bySoujanya RaviApril 3, 2026